"10.1371_journal.pone.0086555","plos one","2014-01-27T00:00:00Z","Danuta M Skowronski; Marie-Eve Hamelin; Gaston De Serres; Naveed Z Janjua; Guiyun Li; Suzana Sabaiduc; Xavier Bouhy; Christian Couture; Anders Leung; Darwyn Kobasa; Carissa Embury-Hyatt; Erwin de Bruin; Robert Balshaw; Sophie Lavigne; Martin Petric; Marion Koopmans; Guy Boivin","British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; University of British Columbia, Vancouver, British Columbia, Canada; Centre Hospitalier Universitaire de Québec [University Hospital Centre of Québec], Québec, Canada; Laval University, Québec, Canada; Institut National de Santé Publique du Québec [National Institute of Health of Québec], Québec, Canada; Institut universitaire de cardiologie et pneumologie de Québec, Québec, Québec, Canada; Public Health Agency of Canada, Winnipeg, Manitoba, Canada; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada; Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada; Laboratory for Infectious Disease Research, Diagnostics and Screening, Centre for Infectious Disease Control (CIDC), Rijksinstituut voor Volksgezondheid en Milieu (RIVM) [National Institute of Public Health and the Environment], Bilthoven, The Netherlands; Simon Fraser University, Burnaby, British Columbia, Canada; Viroscience Department, Erasmus MC, Rotterdam, The Netherlands","Conceived and designed the experiments: DMS GDS MEH NZJ GB. Performed the experiments: MEH SS XB CC AL CEH SL MP GB MK EDB. Analyzed the data: NZJ GL DMS MEH GDS EDB RB. Contributed reagents/materials/analysis tools: SS XB CC AL CEH MK EDB RB. Wrote the paper: DMS MEH GDS NZJ GL SS XB CC AL DK CEH SL MP GB MK EDB RB.","The authors have the following conflicts: Gaston De Serres has received research grants from GSK and Sanofi Pasteur and received reimbursement for travel fee to attend a GSK ad hoc Advisory board meeting. Guy Boivin has received research grants from GSK and Medicago. Marion Koopmans and Erwin de Bruin have received grants from the Dutch government, from the Wellcome trust, and from the European commission. Before joining the BC Centre for Disease Control, Robert Balshaw was previously (within the last 36 months) Director of Biometrics for Syreon Corporation, a contract research organization which has conducted clinical trials on behalf of pharmaceutical companies. The other authors declare that they have no conflicts of interest to report. This does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials.","2014","01","Danuta M Skowronski","DMS",17,TRUE,5,11,7,17,TRUE,TRUE,FALSE,0,NA,FALSE
